The July 8-9 NATO summit meeting in Warsaw, Poland, is previewed in a new report from the Congressional Research Service.
“Among other things, NATO leaders are expected to announce the rotational deployment of 4,000 troops to Poland and the three Baltic states, an expanded training mission for Iraqi soldiers, and additional NATO support for Afghanistan and Ukraine. NATO leaders will also assess member state progress in implementing defense spending and capabilities development commitments, a key U.S. priority. Finally, NATO is expected to formally invite Montenegro to become the 29th member of the alliance,” the report said.
The new report includes data on alliance defense spending and defense spending by individual NATO member states. See NATO’s Warsaw Summit: In Brief, June 30, 2016.
Other new and updated reports from the Congressional Research Service include the following.
“Right-Sizing” the National Security Council Staff?, CRS Insight, June 30, 2016
Diversity, Inclusion, and Equal Opportunity in the Armed Services: Background and Issues for Congress, updated July 1, 2016
Sanctuary Jurisdictions and Criminal Aliens: In Brief, updated July 1, 2016
Brazil in Crisis, CRS Insight, updated July 6, 2016
State Voter Identification Requirements: Analysis, Legal Issues, and Policy Considerations, updated July 5, 2016
Derivatives: Introduction and Legislation in the 114th Congress, July 1, 2016
Overview of Health Insurance Exchanges, updated July 1, 2016
Military Benefits for Former Spouses: Legislation and Policy Issues, updated July 1, 2016
The Freedom of Information Act Turns Fifty & Is Revised, CRS Legal Sidebar, July 1, 2016
Employing a living approach to evidence synthesis, disseminated at a national level, is a streamlined way to enable evidence-based decision-making nationwide.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.